Picture of Alexandria Real Estate Equities logo

ARE — Alexandria Real Estate Equities News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedLarge CapNeutral

BMO initiates coverage on Alexandria Real Estate on life sciences strength

** BMO initiates coverage on the real estate investment trust Alexandria Real Estate Equities ARE.N with "outperform" rating; PT at $100

** New PT represents an upside of 16.4% from the stock's last close

** Brokerage says ARE's core business is facing pressure from oversupply and weak demand, but its strong portfolio and discounted valuation could benefit from a rebound in the biopharma sector

** BMO views co as a resilient and well-positioned leader in life sciences, offering attractive potential for steady returns and growth

** Brokerage expects 2025 funds from operations (FFO) of $8.33

** Six of 14 brokerages rate the stock "buy" or higher, eight "hold"; their median PT is $91- data compiled by LSEG

** As of last close, stock had fallen 12% YTD

 (Reporting by Apratim Sarkar)

 ((Apratim.Sarkar@thomsonreuters.com))

Recent news on Alexandria Real Estate Equities

See all news